Rare diseases
Investigational molecules
Locations
Study Comparing Olaparib and Chemotherapy for Patients with Recurrent Ovarian Cancer After Surgery
ItalyStudy of EG-70 for Patients with Non-Muscle Invasive Bladder Cancer Unresponsive to BCG or High-Risk Patients New to BCG or with Incomplete BCG Treatment
ItalyStudy of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia
ItalyStudy on the Effects and Safety of Daratumumab, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Plasmablastic Lymphoma
ItalyStudy on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy
ItalyStudy Comparing Gemcitabine and Paclitaxel with Drug Combination for Patients with Advanced Pancreatic Cancer
ItalyStudy of Olaparib for Patients with Recurrent Ovarian Cancer Without BRCA Gene Mutations
ItalyStudy of Roginolisib for Patients with Advanced Uveal Melanoma
ItalyStudy of gemtuzumab ozogamicin with chemotherapy for adults aged 18-60 with newly diagnosed favorable-intermediate-risk acute myeloid leukemia
ItalyStudy on the Safety of Roginolisib and Ruxolitinib for Patients with Myelofibrosis Unresponsive to JAK Inhibitors
ItalyStudy on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations
ItalyStudy to Optimize Cytokine Release Syndrome for Glofitamab with Gemcitabine and Oxaliplatin in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
